Since underlying kidney disease is a strong risk factor for cardiovascular disease and kidney disease augments plasma levels of APOC3, we asked whether silencing APOC3 would have the same protective effect in a model of type 2 diabetes that also has underlying kidney disease. The gene discussed is APOC3; the disease is cardiovascular disorder.